These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 28968192)

  • 1. Harnessing the Properties of Natural Products.
    Boufridi A; Quinn RJ
    Annu Rev Pharmacol Toxicol; 2018 Jan; 58():451-470. PubMed ID: 28968192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A general strategy for diversifying complex natural products to polycyclic scaffolds with medium-sized rings.
    Zhao C; Ye Z; Ma ZX; Wildman SA; Blaszczyk SA; Hu L; Guizei IA; Tang W
    Nat Commun; 2019 Sep; 10(1):4015. PubMed ID: 31488839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pseudo-natural products and natural product-inspired methods in chemical biology and drug discovery.
    Grigalunas M; Burhop A; Christoforow A; Waldmann H
    Curr Opin Chem Biol; 2020 Jun; 56():111-118. PubMed ID: 32362382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expanding the medicinally relevant chemical space with compound libraries.
    López-Vallejo F; Giulianotti MA; Houghten RA; Medina-Franco JL
    Drug Discov Today; 2012 Jul; 17(13-14):718-26. PubMed ID: 22515962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fragment-based screening with natural products for novel anti-parasitic disease drug discovery.
    Liu M; Quinn RJ
    Expert Opin Drug Discov; 2019 Dec; 14(12):1283-1295. PubMed ID: 31512943
    [No Abstract]   [Full Text] [Related]  

  • 6. Principle and design of pseudo-natural products.
    Karageorgis G; Foley DJ; Laraia L; Waldmann H
    Nat Chem; 2020 Mar; 12(3):227-235. PubMed ID: 32015480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening techniques for the identification of bioactive compounds in natural products.
    Fu Y; Luo J; Qin J; Yang M
    J Pharm Biomed Anal; 2019 May; 168():189-200. PubMed ID: 30825802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Harnessing the potential of natural products in drug discovery from a cheminformatics vantage point.
    Rodrigues T
    Org Biomol Chem; 2017 Nov; 15(44):9275-9282. PubMed ID: 29085945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploring Natural Products from the Biodiversity of Pakistan for Computational Drug Discovery Studies: Collection, Optimization, Design and Development of A Chemical Database (ChemDP).
    Mirza SB; Bokhari H; Fatmi MQ
    Curr Comput Aided Drug Des; 2015; 11(2):102-9. PubMed ID: 26343150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biology-oriented synthesis: harnessing the power of evolution.
    van Hattum H; Waldmann H
    J Am Chem Soc; 2014 Aug; 136(34):11853-9. PubMed ID: 25074019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lysine acetyltransferase inhibitors: structure-activity relationships and potential therapeutic implications.
    Fiorentino F; Mai A; Rotili D
    Future Med Chem; 2018 May; 10(9):1067-1091. PubMed ID: 29676588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The polypharmacology of natural products.
    Ho TT; Tran QT; Chai CL
    Future Med Chem; 2018 Jun; 10(11):1361-1368. PubMed ID: 29673257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A screening pattern recognition method finds new and divergent targets for drugs and natural products.
    Wassermann AM; Lounkine E; Urban L; Whitebread S; Chen S; Hughes K; Guo H; Kutlina E; Fekete A; Klumpp M; Glick M
    ACS Chem Biol; 2014 Jul; 9(7):1622-31. PubMed ID: 24802392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The structural modification of natural products for novel drug discovery.
    Yao H; Liu J; Xu S; Zhu Z; Xu J
    Expert Opin Drug Discov; 2017 Feb; 12(2):121-140. PubMed ID: 28006993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Charting, navigating, and populating natural product chemical space for drug discovery.
    Lachance H; Wetzel S; Kumar K; Waldmann H
    J Med Chem; 2012 Jul; 55(13):5989-6001. PubMed ID: 22537178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Why Are the Majority of Active Compounds in the CNS Domain Natural Products? A Critical Analysis.
    Bharate SS; Mignani S; Vishwakarma RA
    J Med Chem; 2018 Dec; 61(23):10345-10374. PubMed ID: 29989814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Data Resources for the Computer-Guided Discovery of Bioactive Natural Products.
    Chen Y; de Bruyn Kops C; Kirchmair J
    J Chem Inf Model; 2017 Sep; 57(9):2099-2111. PubMed ID: 28853576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mass spectrometry-based strategies for screening of bioactive natural products.
    Xin GZ; Zhou JL; Qi LW; Li P
    Comb Chem High Throughput Screen; 2011 Feb; 14(2):93-103. PubMed ID: 21118084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natural allosteric modulators and their biological targets: molecular signatures and mechanisms.
    Bruder M; Polo G; Trivella DBB
    Nat Prod Rep; 2020 Apr; 37(4):488-514. PubMed ID: 32048675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A click chemistry assay to identify natural product ligands for pre-microRNAs.
    Garner AL; Lorenz DA; Gallagher EE
    Methods Enzymol; 2019; 623():85-99. PubMed ID: 31239059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.